Visão geral da empresa MaxCyte
1 escritórioLocalizações
Since 1999, our non-viral cell engineering innovations have helped launch pioneering cell and gene therapy projects.
As advanced therapeutic modalities move from concept to clinic, new cell engineering approaches will emerge and mature. MaxCyte will continue to leverage our best-in-class electroporation technology and experience in the industry to support our partners in pushing the frontiers of bio-based medicines.
As advanced therapeutic modalities move from concept to clinic, new cell engineering approaches will emerge and mature. MaxCyte will continue to leverage our best-in-class electroporation technology and experience in the industry to support our partners in pushing the frontiers of bio-based medicines.
